Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia

Published:2003-03-18 Issue:7 Volume:97 Page:1711-1720
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Tsimberidou Apostolia M.,Kantarjian Hagop M.,Cortes Jorge,Thomas Deborah A.,Faderl Stefan,Garcia-Manero Guillermo,Verstovsek Srdan,Ferrajoli Alessandra,Wierda William,Alvarado Yesid,O'Brien Susan M.,Albitar Maher,Keating Michael J.,Giles Francis J.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference54 articles.

1. Richter's syndrome: a report on 39 patients.

2. Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent

3. Malignant lymphoma supervening in chronic lymphocytic leukemia and related disorders. Richter's syndrome: A study of 25 cases

4. Richter's syndrome in chronic lymphocytic leukemia

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SOHO State of the Art Updates and Next Questions | Contemporary Standard of Care Therapy for Richter's Transformation and Future Directions;Clinical Lymphoma Myeloma and Leukemia;2024-07

2. A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia;Blood Advances;2024-05-17

3. Are we closer to a standard of care for Richter’s syndrome? Novel treatments on the horizon;Expert Review of Hematology;2024-05-03

4. Venetoclax plus dose-adjusted R-EPOCH (VR-DA-EPOCH) or G-EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience;Annals of Hematology;2024-01-22

5. Richter transformation—is there light at the end of this tunnel?;Hematology;2023-12-08